Experientia

, Volume 30, Issue 9, pp 1065–1067 | Cite as

Effect of 6-amino-nicotinamide on the tolerance of mice to hypoxic hypoxia

  • H. H. Berlet
Specialia Pharmacologica
  • 15 Downloads

Keywords

Glucose Hypoxic Hypoxia Anaerobe Utilisation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Zusammenfassung

Eine einmalige Injektion von 6-Aminonicotinamid (6-ANA) steigerte die Sauerstoffman-gelresistenz von Mäusen in einer Atmosphäre mit 5% O2 und 95% N2. Hyperglykämie und Hypothermie, systemische Wirkungen von 6-ANA, konnten als Ursachen der gesteigerten Resistenz ausgeschlossen werden. Es wird deswegen vermutet, dass 6-ANA die anaerobe Utilisation von Glucose im Gehirn fördert.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    M. McIlwain,Chemical Exploration of the Brain (Elsevier Publishing Company, Amsterdam 1963).Google Scholar
  2. 2.
    G. E. Glock andP. McLean, Biochem. J.56, 171 (1954).PubMedGoogle Scholar
  3. 3.
    R. M. Guerra, E. Melgar andM. Villavicencio, Biochem. biophys. Acta.148, 356 (1967).PubMedGoogle Scholar
  4. 4.
    K. Y. Hostetler andB. R. Landau, Biochemistry6, 2961 (1967).CrossRefPubMedGoogle Scholar
  5. 5.
    K. Y. Hostetler, B. R. Landau, R. J. White, M. S. Albin andD. Yashon, J. Neurochem.17, 33 (1970).PubMedGoogle Scholar
  6. 6.
    H. Herken, K. Lange andH. Kolbe, Biochem. biophys. Res. Commun.36, 93 (1969).CrossRefPubMedGoogle Scholar
  7. 7.
    F. W. Stemler, J. E. Wiebers andW. A. Hiestand, Am. J. Physiol.163, 400 (1950).PubMedGoogle Scholar
  8. 8.
    A. Brunnemann andH. Coper, Arch. exp. Path. Pharmak.246, 63 (1963).Google Scholar
  9. 9.
    F. H. Schmidt, K. von Dahl, P. Heidrich andH. Storck, Clin. chim. Acta, in press.Google Scholar
  10. 10.
    H. E. Himwich,Brain Metabolism and Cerebral Disorders (The Williams & Wilkins Company, Baltimore 1951).Google Scholar
  11. 11.
    D. von Herrath, Inaug. Dissertation (Freie Universität, Berlin 1968).Google Scholar
  12. 12.
    R. Broniszewska-Ardelt andJ. F. Jongkind, J. Neurochem.18, 2237 (1971).PubMedGoogle Scholar
  13. 13.
    H. H. Loeschke, Pflügers Arch. ges. Physiol.246, 44 (1942).CrossRefGoogle Scholar
  14. 14.
    S. W. Britton andR. F. Kline, Am. J. Physiol.145, 190 (1945).Google Scholar
  15. 15.
    E. A. Brunner, J. V. Passoneau andC. Molstad, J. Neurochem.18, 2301 (1971).PubMedGoogle Scholar
  16. 16.
    H. Herken, K. Keller, H. Kolbe, K. Lange andH. Schneider, Klin. Wschr.51, 644 (1973).CrossRefPubMedGoogle Scholar
  17. 17.
    Acknowledgment. The technical assistance of MissI. Bonsmann is gratefully acknowledged.Google Scholar

Copyright information

© Birkhäuser Verlag 1974

Authors and Affiliations

  • H. H. Berlet
    • 1
  1. 1.Institute of Pathochemistry and General NeurochemistryUniversity of HeidelbergHeidelberg(Federal Republic of Germany)

Personalised recommendations